SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

Click Holdings is trending as traders discuss its potential for a significant breakout, drawing comparisons to other Hong Kong-based stocks with crypto tie-ins that have recently seen substantial gains. Community members are closely watching the low float and anticipating news, particularly regarding the company's previously announced plans for a crypto treasury. Bullish investors hope CLIK can mirror the success of similar plays, while others express concerns about its ability to execute and sustain momentum.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending amid discussions around Amazon's competitive moves and their potential impact on the ad-tech landscape; the community is debating the validity of recent reports and the company's long-term prospects in light of these challenges. Some investors view the dip as a buying opportunity, while others express concern over the stock's performance and potential market manipulation. The company's response and upcoming earnings are key points of focus.

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

Picard Medical Inc.

Picard Medical (PMI) is trending amid significant stock volatility, prompting the company to release a statement clarifying they are unaware of any undisclosed material changes. The community is actively discussing potential dilution, short covering, and speculating about a possible pump and dump, while some remain bullish, citing the company's unique position in the artificial heart market.

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Neuphoria Therapeutics Inc.

NEUP is trending due to a significant surge, with the community citing recent insider buying activity as a possible catalyst. Discussions also mention a milestone payment from Merck related to their Alzheimer's program. Some traders are closely watching the low float and suggesting a potential short squeeze, while others express caution due to potential dilution.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending as traders discuss a potential short squeeze, noting high borrowing costs and a seemingly limited float. Community members are debating the impact of insider activity and monitoring short interest data. Some investors suggest a buy-and-hold strategy, while others point to technical indicators.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending due to an FDA investigation into increased reports of allergic reactions to specific lots of intravenous immunoglobulin (IGIV) products, including two ADMA lots, leading to a voluntary recall. While some community members view this as a buying opportunity, citing the company's strong fundamentals and potential for a pre-earnings run-up, others are concerned about potential impacts on future earnings and are closely watching for management's response and share buyback activity. The community is also discussing the broader context of hypersensitivity reactions to IGIV drugs and ADMA's growth potential within the plasma-derived therapies market.

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BridgeBio Pharma Inc

BBIO is trending as investors discuss upcoming Phase 3 results and the potential of new drugs in its portfolio, with readouts anticipated before Thanksgiving. Community members are also weighing the long-term potential of the stock, considering its current market cap and future growth prospects. Bullish sentiment is fueled by the protective hedging strategy and possible new drug additions, while others are eyeing call options.

Meet DragonWifBeard: The world's first AI-powered pet dragon!  More Than Just Scales: DragonWifBeard is a real-life bearded dragon revolutionizing the pet experience. He's not just any reptile – he's equipped with cutting-edge Eliza AI agent, giving him a unique personality and the ability to interact with his environment in unprecedented ways. The Future of Companionship: This groundbreaking project merges the love for pets with the limitless possibilities of AI. Witness the dawn of a new era in companionship with DragonWithBeard.

DragonWifBeard

DragonWifBeard ($DWB) is gaining attention, with community members promoting it as the next big opportunity. Conversations highlight its availability on Phantom Wallet and its potential for significant gains. The coin is frequently mentioned alongside other popular cryptocurrencies like Bitcoin, Solana, and Shiba Inu.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

Slap is trending as the community rallies around the coin's real-world partnerships and sponsored pro athletes.  Discussions highlight the team's grindset mentality and the coin's universal appeal as more than just a meme.  The project's unique branding and active community involvement are also key talking points.

Clanker is an autonomous agent for deploying tokens. Currently, users may request clanker to deploy an ERC-20 token on Base by tagging it @clanker on Farcaster.

tokenbot

Clanker Crypto is trending as the community discusses its potential for significant gains due to its limited supply and recent price movements. Some users point to technical analysis, highlighting breakout patterns, while others speculate about a possible Coinbase listing and its impact on the token's value. The conversation also mentions the broader ecosystem and related tokens.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Omnicom Group Stock Improves 3.2% Since Q3 Earnings Beat

OMC posts strong Q3 results with earnings and revenue gains fueled by solid organic growth across key markets.

Equifax Q3 Earnings & Revenues Surpass Estimates, Increase Y/Y

EFX posts impressive results in Q3, wherein earnings and revenues climb year over year, prompting a full-year guidance raise.

Lightning Round: Factset Research Systems is way too cheap, says Jim Cramer

'Mad Money' host Jim Cramer weighs in on stocks including: Factset and Freeport-McMoRan...

NYSE Content Advisory: Pre-Market Update + LA Times Media Group takes step towards trading debut

NYSE Content Advisory: Pre-Market Update + LA Times Media Group takes step towards trading debut NYSE Content Advisory: Pre-Market Update + LA Times Media Group takes step towards trading debut PR...

Pricing & Cost Control Benefit WM's Profitability Amid Low Liquidity

WM drives profitability with pricing discipline and cost control, while the Stericycle buyout adds growth potential but strains liquidity.

Paychex Q1 Earnings & Revenues Surpass Estimates, Increase Y/Y

PAYX posts solid first-quarter fiscal 2026 results, with revenues increasing 16.8% and earnings rising 5.2% year over year.

Paychex Gears Up to Report Q1 Earnings: What's in the Offing?

PAYX prepares for first-quarter fiscal 2026 results with revenues expected to rise 16.6% y/y, fueled by strong segmental growth and contributions from Paycor.

Accenture Earnings Beat Estimates in Q4, Revenues Increase Y/Y

ACN posts earnings beat for fourth-quarter fiscal 2025, with growth across segments and strong bookings, while issuing an upbeat fiscal 2026 guidance.

Company News for Sep 19, 2025

Companies in The News Are: DRI,FDS,CBRL,META

Wells Fargo analysts said that Thursday’s selloff among financial data provider stocks was unwarranted due to limited overlap.S&amp;P Global and Moody’s stock fell 6.7% and 5.8%, respectively, during the regular trading session. All three stocks logged their worst day since the Trump tariff-driven market turmoil in April.The declines came after FactSet reported its annual adjusted earnings below Wall Street’s estimates, amid concerns over a slowdown in client spending and increased competition in the sector. FactSet projected its 2026 adjusted earnings between $16.90 and $17.60, while analysts projected earnings of $18.26 per share. The stock slumped nearly 11% on Thursday.“We’re taking a conservative approach to our guidance to reflect the current environment of longer sales cycles and more rigorous client approval processes,” Chief Financial Officer Helen Shan said, before noting that the company remains confident about its competitive position and market demand.According to TheFly, Wells Fargo cut the firm's price target on FactSet to $355 from $296 and maintained an ‘Underweight’ rating on the shares. The brokerage noted that FactSet’s outlook seemed conservative and its upbeat annual subscription value was overshadowed by mention of rising competition due to AI and margin pressures from increased investments.“There is a lot of competitive dynamics, as in new competitors, startups, and traditional competitors, all in an AI arms race,” CEO Sanoke Viswanathan said.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/FDS">FactSet</a> and <a href="https://stocktwits.com/symbol/SPGI">S&amp;P Global</a> was still in the ‘extremely bullish’ territory at the time of writing, while traders were ‘bullish’ about <a href="https://stocktwits.com/symbol/MCO">Moody’s</a>.<figure class="image"><img style="aspect-ratio:721/84;" src="https://news.stocktwits-cdn.com/FDS_Sept_19_JPG_1b3361c42a.webp" alt="FDS’s Sentiment Meter and Message Volume as of 01:00 a.m. ET on Sept. 19, 2025 | Source: Stocktwits" width="721" height="84"><figcaption>FDS’s Sentiment Meter and Message Volume as of 01:00 a.m. ET on Sept. 19, 2025 | Source: Stocktwits</figcaption></figure>“If you're here to buy and hold for 3-5 years or more. It is good to start [a] position here at small tranches,” one user said about S&amp;P Global.<stembedurl>https://stocktwits.com/QQQZEBRA/message/629178957</stembedurl>“On valuations, it has plummeted to a ratio last seen during the 2008 crash as well. This could be an exceptional buy if you believe that its platform is sticky and that recent earnings weakness is temporary,” another user said about FactSet.<stembedurl>https://stocktwits.com/lextrading/message/629231473</stembedurl>S&amp;P Global, Moody’s, and FactSet stocks have all underperformed the broader markets this year.<figure class="image"><img style="aspect-ratio:2400/1240;" src="https://news.stocktwits-cdn.com/koyfin_20250919_011805087_png_e7920cbbc6.webp" alt="YTD performance comparison which shows how S&amp;P 500 has far outperformed the three stocks. (Source: Koyfin data)" width="2400" height="1240"><figcaption>S&amp;P Global and Moody's are up only marginally while FactSet is down over 37%.</figcaption></figure>Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-fed-ex-stock-rise-after-hours-today/chDdY7SR3b6">FedEx Stock Gains After-Hours On Q1 Earnings Beat, Sees $1B Hit From Trade Volatility Unleashed By Trump Tariffs</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Traders work on the floor of the New York Stock Exchange during morning trading on October 04, 2023 in New York City. 

Wells Fargo Calls S&P Global, Moody’s Selloff ‘Unwarranted’ After FactSet’s Dour Forecast

The financial data provider stocks logged their worst day since the Trump tariff-driven market turmoil in April.

Equity

FactSet Research Systems Inc. (the Company or FactSet) is a global financial digital platform and enterprise solutions provider with open and flexible technologies that aims to supercharge financial intelligence. Since inception, global financial professionals have utilized the company's content and multi-asset class solutions across each stage of the investment process. FactSet's goal is to provide a seamless user experience spanning idea generation, research, portfolio construction, trade execution, performance measurement, risk management, reporting, and portfolio analysis, in which the company serves the front, middle, and back offices to drive productivity and improved performance. FactSet's flexible, open data and technology solutions can be implemented both across the investment portfolio lifecycle or as standalone components serving different workflows in the organization. FactSet is focused on growing the business throughout each of its three segments, the Americas, EMEA (formerly known as Europe), and Asia Pacific. FactSet revised its internal organization within each segment to offer data, products and analytical applications by firm type: Institutional Buyside, Dealmakers, Wealth, and Partnerships and CGS. The company believes organization by firm type better aligns with its clients, the long-term view of its business and commitment to investing for growth and efficiency. FactSet currently serves financial professionals, which include portfolio managers, investment research professionals, investment bankers, risk and performance analysts, wealth advisors and corporate clients. FactSet provides both insights on global market trends and intelligence on companies and industries, as well as capabilities to monitor portfolio risk and performance and to execute trades. The company combines dedicated client service with open and flexible technology offerings, such as a configurable desktop and mobile platform, comprehensive data feeds, an open marketplace and digital portals and application programming interfaces (APIs). The company’s revenue is primarily derived from subscriptions to products and services such as workstations, analytics, enterprise data, and research management. FactSet Research Systems was founded by Howard E. Wille and Charles J. Snyder in September 1978 and is headquartered in Norwalk, CT.

Factset Research Systems Inc.

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

FDS
Factset Research Systems Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest FDS News

FDSFactset Research Systems Inc.